ChromSCape_single_cell_ChIP_seq_matrices

@page { margin: 0.79in } p { margin-bottom: 0.1in; direction: ltr; line-height: 120%; text-align: left; orphans: 2; widows: 2 } a:link { so-language: zxx } a.western:visited { so-language: fr-FR } a.cjk:visited { so-language: zh-CN } a.ctl:visited { so-language: hi-IN } @page { margin: 0.79in } p { margin-bottom: 0.1in; direction: ltr; line-height: 120%; text-align: left; orphans: 2; widows: 2 } a:link { so-language: zxx } a.western:visited { so-language: fr-FR } a.cjk:visited { so-language: zh-CN } a.ctl:visited { so-language: hi-IN } Mouse stromal cells from PDX count matrices reformatted to be inputed in ChromSCape (https://github.com/vallotlab/ChromSCape), two of which had not been analyzed in our previous study (Grosselin et al., 2019, https://www.nature.com/articles/s41588-019-0424-9). @page { margin: 0.79in } p { margin-bottom: 0.1in; direction: ltr; line-height: 120%; text-align: left; orphans: 2; widows: 2 } a:link { so-language: zxx } a.western:visited { so-language: fr-FR } a.cjk:visited { so-language: zh-CN } a.ctl:visited { so-language: hi-IN } The samples correspond to the mouse cells from patient-derived xenograft (PDX) originating from two different human donors. The HBCx-22 and HBCx-22-TamR datasets correspond to mouse cells from a pair of luminal ER⁺ breast PDXs: HBCx-22, responsive to Tamoxifen and HBCx-22-TamR, resistant to Tamoxifen. The HBCx-95 and HBCx-95-CapaR correspond to a triple-negative breast cancer (TNBC) tumor model of acquired resistance to chemotherapy. Row names of the matrices are 50,000-bp binned regions; Column names are barcodes corresponding to single cell; Cells contains raw counts, in mm10 reference.